References
1. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. The Cochrane database of systematic reviews. 2017 Mar 21;3:Cd004454.
2. Stutchfield P, Whitaker R, Russell I, Antenatal Steroids for Term Elective Caesarean Section Research T. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ. 2005 Sep 24;331(7518):662.
3. Nada AM, Shafeek MM, El Maraghy MA, Nageeb AH, Salah El Din AS, Awad MH. Antenatal corticosteroid administration before elective caesarean section at term to prevent neonatal respiratory morbidity: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:88-91.
4. Ahmed MR, Sayed Ahmed WA, Mohammed TY. Antenatal steroids at 37 weeks, does it reduce neonatal respiratory morbidity? A randomized trial. J Matern Fetal Neonatal Med. 2015 Aug;28(12):1486-90.
5. Moses RG, Wong VC, Lambert K, Morris GJ, San Gil F. The prevalence of hyperglycaemia in pregnancy in Australia. The Australian & New Zealand journal of obstetrics & gynaecology. 2016 Aug;56(4):341-5.
6. Australian Institute of Health and Welfare (AIWH). Australia’s Mothers and Babies 2014 - in brief. Perinatal statistics series no. 32 cat. no. PER 87. Canberra. AIHW. 2016 2016.
7. Abell SK, Boyle JA, de Courten B, Knight M, Ranasinha S, Regan J, et al. Contemporary type 1 diabetes pregnancy outcomes: impact of obesity and glycaemic control. Med J Aust. 2016 Aug 15;205(4):162-7.
8. Abell SK, Boyle JA, de Courten B, Soldatos G, Wallace EM, Zoungas S, et al. Impact of type 2 diabetes, obesity and glycaemic control on pregnancy outcomes. The Australian & New Zealand journal of obstetrics & gynaecology. 2016 Sep 05.
9. Amiya RM, Mlunde LB, Ota E, Swa T, Oladapo OT, Mori R. Antenatal Corticosteroids for Reducing Adverse Maternal and Child Outcomes in Special Populations of Women at Risk of Imminent Preterm Birth: A Systematic Review and Meta-Analysis. PloS one. 2016 02/03
03/27/received
01/06/accepted;11(2):e0147604.
10. Gyamfi-Bannerman C, Thom EA. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016 Aug 04;375(5):486-7.
11. Becquet O, El Khabbaz F, Alberti C, Mohamed D, Blachier A, Biran V, et al. Insulin treatment of maternal diabetes mellitus and respiratory outcome in late-preterm and term singletons. BMJ Open. 2015 Jun 02;5(6):e008192.
12. Saccone G, Berghella V. Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials. BMJ. 2016 Oct 12;355:i5044.
13. Antenatal corticosteroids given to women prior to birth to improve fetal, infant, child and adult health: Clinical practice guidelines. Auckland: Liggins Institute, The University of Auckland; 2015.
14. Committee on Obsteric Practice. American College of Obstetricians and Gynecologists. Committee Opinion Number 713: Antenatal Corticosteroid Therapy for Fetal Lung Maturation. Obsterics and Gynecology. 2017;130:e102-9.
15. Royal College of Obstetricians and Gynaecologists. Antenatal Corticosteroids to Reduce Neonatal Morbidity (Green-top Guideline No. 7). Green Top Guidelines. 2010 (updated 2014).
16. Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita ATN, Reddy UM, Saade GR, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. New England Journal of Medicine. 2016;374(14):1311-20.
17. Paul R, Murugesh C, Chepulis L, Tamatea J, Wolmarans L. Should antenatal corticosteroids be considered in women with gestational diabetes before planned late gestation caesarean section. The Australian & New Zealand journal of obstetrics & gynaecology. 2019 Jun;59(3):463-6.
18. Ashley N. Battarbee SAKAB. Management of diabetic women with threatened preterm birth; a survey of Maternal Fetal Medicine Providers. The Journal of Maternal Fetal & Neonatal Medicine. 2019;33(17):2941-9.
19. Tuohy JF, Bloomfield FH, Harding JE, Crowther CA. Patterns of antenatal corticosteroid administration in a cohort of women with diabetes in pregnancy. PLoS One. 2020;15(2):e0229014.
20. Jolley JA, Rajan PV, Petersen R, Fong A, Wing DA. Effect of antenatal betamethasone on blood glucose levels in women with and without diabetes. Diabetes Res Clin Pract. 2016 Aug;118:98-104.
21. Dashora U, Murphy HR, Temple RC, Stanley KP, Castro E, George S, et al. Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes. Diabet Med. 2018 Aug;35(8):1005-10.
22. Shanks AL, Grasch JL, Quinney SK, Haas DM. Controversies in antenatal corticosteroids. Semin Fetal Neonatal Med. 2019 Jun;24(3):182-8.
23. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. The Lancet. 2005 //28;365(9474):1856-62.
24. Kugelman A, Colin AA. Late preterm infants: near term but still in a critical developmental time period. Pediatrics. 2013 Oct;132(4):741-51.
25. Chan E, Quigley MA. School performance at age 7 years in late preterm and early term birth: a cohort study. Arch Dis Child Fetal Neonatal Ed. 2014 Nov;99(6):F451-7.
26. Consortium on Safe L, Hibbard JU, Wilkins I, Sun L, Gregory K, Haberman S, et al. Respiratory morbidity in late preterm births. JAMA. 2010 Jul 28;304(4):419-25.
27. Clark SL, Miller DD, Belfort MA, Dildy GA, Frye DK, Meyers JA. Neonatal and maternal outcomes associated with elective term delivery. Am J Obstet Gynecol. 2009 Feb;200(2):156 e1-4.
28. Stutchfield PR, Whitaker R, Gliddon AE, Hobson L, Kotecha S, Doull IJ. Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial). Arch Dis Child Fetal Neonatal Ed. 2013 May;98(3):F195-200.
29. Sibai BM, Caritis SN, Hauth JC, MacPherson C, VanDorsten JP, Klebanoff M, et al. Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. American Journal of Obstetrics and Gynecology. 2000;183(6):1520-4.
30. NICE: National Institute for Health and Care Excellence. Guideline NG3: Diabetes in pregnancy: management Diabetes in pregnancy: management from preconception to the postnatal from preconception to the postnatal period 2015.
31. Starikov R, Dudley D, Reddy UM. Stillbirth in the pregnancy complicated by diabetes. Curr Diab Rep. 2015 Mar;15(3):11.
32. Jobe AH, Schmidt AF. Chapter for antenatal steroids – Treatment drift for a potent therapy with unknown long-term safety seminars in fetal and neonatal medicine. Seminars in Fetal and Neonatal Medicine. 2021.
33. Jobe AH, Goldenberg RL. Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. Am J Obstet Gynecol. 2018 Jul;219(1):62-74.
34. McGillick EV, Morrison JL, McMillen IC, Orgeig S. Intrafetal glucose infusion alters glucocorticoid signaling and reduces surfactant protein mRNA expression in the lung of the late-gestation sheep fetus. Am J Physiol Regul Integr Comp Physiol. 2014 Sep 01;307(5):R538-45.
35. Kaiser JR, Bai S, Gibson N, Holland G, Lin TM, Swearingen CJ, et al. Association Between Transient Newborn Hypoglycemia and Fourth-Grade Achievement Test Proficiency: A Population-Based Study. JAMA Pediatr. 2015 Oct;169(10):913-21.
36. Lucas A MR, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ. 1988;297:1304-8.
37. Sharma A, Davis A, Shekhawat PS. Hypoglycemia in the preterm neonate: etiopathogenesis, diagnosis, management and long-term outcomes. Transl Pediatr. 2017 Oct;6(4):335-48.